Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Angle (AGL)

Price 15.50p on 24-04-2024 at 15:20:09
Change 3.25p 26.53%
Buy 16.00p
Sell 15.00p
Buy / Sell AGL Shares
Last Trade: Buy 9,580.00 at 15.665p
Day's Volume: 12,078,633
Last Close: 12.25p
Open: 14.75p
ISIN: GB0034330679
Day's Range 15.25p - 17.25p
52wk Range: 9.125p - 31.40p
Market Capitalisation: £40m
VWAP: 15.93111p
Shares in Issue: 261m

Recent Trades History Angle (AGL)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 9,580 15.665p Ordinary
15:20:07 - 24-Apr-24
Buy* 2,553 15.6675p Ordinary
15:13:42 - 24-Apr-24
Sell* 17,820 15.26p Ordinary
15:11:16 - 24-Apr-24
Buy* 38 15.6734p Ordinary
15:10:03 - 24-Apr-24
Sell* 3,000 15.3825p Ordinary
15:02:03 - 24-Apr-24
Buy* 25,000 15.675p Ordinary
14:59:12 - 24-Apr-24
Sell* 25,000 15.37555p Ordinary
14:56:58 - 24-Apr-24
Sell* 11,284 15.325p Ordinary
14:49:53 - 24-Apr-24
Buy* 7,746 15.825p Ordinary
14:48:54 - 24-Apr-24
Buy* 7,926 15.7874p Ordinary
14:48:46 - 24-Apr-24

Share Price History for Angle

Time period:
to
Date Open High Low Close Volume

Share News for Angle

Angle shares jump on supplier agreement with with AstraZeneca

24th Apr 2024 10:32

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC. Read More

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

24th Apr 2024 10:10

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday. Read More

IN BRIEF: Angle granted patents in US and Europe for Cellkeep slide

22nd Apr 2024 16:52

Angle PLC - Surrey-based medical diagnostics provider - Says it has been granted a European and US patent for its CellKeep slide. "We are delighted to have secured intellectual property rights for our proprietary CellKeep slide in two major jurisdictions....This is a significant technology advancement for the [circulating tumor cell] liquid biopsy field and another step towards enabling biomarker-guided precision medicine for people with cancer," says Chief Executive Officer Andrew Newland. The CellKeep slide was developed by Angle to reduce cell loss during the transfer of CTCs to the microscope slide and to protect the morphology of the harvested cells. Read More

IN BRIEF: Angle highlights supportive data for DNA analysis tool

22nd Jan 2024 18:03

Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system. Read More

LONDON MARKET CLOSE: Stocks up ahead of US nonfarm payrolls

4th Jan 2024 16:54

(Alliance News) - Stock prices in London closed higher on Thursday, as investors eye the latest US non-farms data. Read More

FTSE 100 Latest
Value8,037.97
Change-6.84

Login to your account

Forgot Password?

Not Registered